Pharmaceutical Technology

AUGUST 15, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional authorisation for Moderna ’s Covid-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron), for use in adults aged 18 years and above. It comprises mRNA-1273 (Spikevax) and a vaccine candidate that acts on the SARS-CoV-2 virus’ BA.1

Vaccine 214

Vaccine Vaccination Immune Response Clinical Trials 214

Scienmag

MARCH 18, 2021

Vaccination alone is unlikely to contain COVID-19 infections in the UK but gradual reopening and high vaccine uptake could minimize future waves of infection COVID-19 vaccines being rolled out in the UK are effective in preventing severe disease, but the extent to which they prevent against infection is still unclear.

Containment 75

Containment Vaccine Vaccination Medicine 75

Pharmaceutical Technology

JUNE 8, 2023

The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60 years and above. The vaccine is indicated for active immunisation to prevent RSV-related lower respiratory tract disease (LRTD) in older adults.

Vaccine 147

Vaccine Vaccination Marketing Manufacturing 147

Pharmaceutical Technology

APRIL 28, 2023

The US Food and Drug Administration (FDA) has approved Pfizer’s 20-valent pneumococcal conjugate vaccine, PREVNAR 20 , to prevent invasive pneumococcal disease (IPD) in infants and children aged six weeks to 17 years. PREVNAR 20 has been developed on the basis of Pfizer’s approved PREVNAR 13 vaccine.

Vaccine 147

Vaccine Vaccination FDA Approval Trials 147

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Vaccine 147

Vaccine Vaccination Development Bacterium 147

Pharmaceutical Technology

JUNE 24, 2022

As regulatory agencies gear up for another round of Covid-19 vaccine deliberations centered on emerging variants, Moderna has released data on its booster’s efficacy against Omicron subvariants. The mRNA-1273.214 booster contains the original Spikevax vaccine and a candidate targeting Omicron BA.1 1 variant of concern.

Vaccine 264

Vaccine Vaccination Antibody Medicine 264

BioTech 365

AUGUST 24, 2021

United States Vaccine Transport Containers Market 2021-2026: Prospects, Trends Analysis, Market Size and Forecasts – ResearchAndMarkets.com United States Vaccine Transport Containers Market 2021-2026: Prospects, Trends Analysis, Market Size and Forecasts – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “United States (..)

Containment 40

Containment Marketing Vaccine Vaccination 40

Pharmaceutical Technology

OCTOBER 18, 2022

Moderna has entered an agreement with Gavi, the Vaccine Alliance, with regard to the delivery of Covid-19 vaccines to lower-income countries supported by the Gavi COVAX Advance Market Commitment (AMC). According to the deal, the parties will cancel pending orders under the existing Covid-19 vaccine supply agreement for this year.

Vaccine 130

Vaccine Vaccination Gene Therapy Containment 130

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 21, 2024

With a fatality rate 20 times that of COVID-19, and no vaccine, Disease X could swiftly bring humanity to its knees. Few would be left untouched by the pathogen were it to gain hold, causing healthcare systems to crumble and economies to collapse as the world once again tried to contain a force of nature. […]

Containment 201

Containment Vaccine Vaccination Clinical Trials 201

Medical Xpress

APRIL 13, 2023

Since September, 2022, bivalent mRNA vaccines—which contain elements from both the original wild type COVID strain and an updated component from the omicron strain—have replaced older style monovalent boosters in the U.S., Israel, and other countries.

Vaccine 98

Vaccine Vaccination Containment 98

Pfizer

AUGUST 22, 2022

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial.

Containment 97

Containment Production Vaccine Vaccination 97

STAT News

APRIL 24, 2023

Marburg could soon become the second virus in the past year to have experimental vaccine candidates ready for testing under an emergency use listing. Until this point, no licensed vaccines or treatments are available for Marburg. With the whole region on high alert, a safe and effective vaccine really couldn’t come soon enough.

Vaccine 111

Vaccine Vaccination Containment Licensing 111

NPR Health - Shots

NOVEMBER 10, 2022

Since the outbreak began in September, eight children have died — and there is no approved vaccine. But doctors are hopeful that public health measures may be enough to stop the spread. Image credit: Hajarah Nalwadda/AP)

Containment 105

Containment Doctor Doctors Vaccine 105

Pfizer

JULY 13, 2022

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), Due To The Potential Presence of Visible Particulate. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a single patient use fliptop vial.

Containment 98

Containment Production Vaccine Vaccination 98

Pharmaceutical Technology

MAY 12, 2023

BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity. The in vivo study, conducted in mice, involved a phosphatidylserine-containing nano-formulation of mRNA supplied by BioNTech, distinct from traditional lipid nanocrystals (LNCs).

Vaccine 130

Vaccine Vaccination In-Vivo In-Vitro 130

Pharmaceutical Technology

MAY 25, 2023

Clover Biopharmaceuticals has established a commercial collaboration with Keyuan Xinhai (Beijing) Medical Products Trading (Kyuan Trade) for the launch of its quadrivalent seasonal influenza vaccine, AdimFlu-S (QIS), in China. The vaccine contains haemagglutinin from four influenza virus strains, two A and two B.

Vaccine 262

Vaccine Vaccination Containment Sales 262

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 2, 2023

Experts have advocated for immunizing both young boys and girls against human papillomavirus (HPV) with latest generation vaccines like Gardasil-9 to address the increasing incidences of cancer cases in India. Gardasil-9 is India’s first gender-neutral HPV vaccine.

Containment 166

Containment Vaccine Vaccination Clinical Trials 166

pharmaphorum

JUNE 9, 2022

Moderna’s new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company’s original Spikevax shot in a head-to-head clinical trial. It has predicted sales of COVID-19 vaccines will be around $21 billion this year. Three-month data will be reported later this summer.

Vaccine 105

Vaccine Vaccination Containment Clinical Trials 105

XTalks

FEBRUARY 21, 2022

BioNTech announced its new vaccine manufacturing approach in Africa where the company will ship modular factories, called the BioNTainer, to the continent to enable domestic production of the vaccines to help increase supplies. Related: BioNTech to Build First mRNA Vaccine Production Plant in Africa. Photo source: BioNTech.

Vaccine 100

Vaccine Vaccination Production Manufacturing 100

Medical Xpress

FEBRUARY 17, 2023

More than 33 million children in several southern African countries have been vaccinated against polio, part of ongoing efforts to eradicate the infectious paralytic disease that has been largely contained in much of the world, the World Health Organization announced on Friday.

Vaccine 75

Vaccine Vaccination Containment 75

BioSpace

OCTOBER 12, 2021

It’s not the COVID-19 vaccine that will get you. The real cause for concern is the virus, and it lies in the fact that both male and female reproductive organs contain cell receptors the virus targets.

Vaccine 87

Vaccine Vaccination Containment 87

Medical Xpress

DECEMBER 1, 2022

In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate containing an adjuvant, a substance that enhances immune responses, elicited durable neutralizing antibody responses to SARS-CoV-2 (..)

Vaccine 75

Vaccine Vaccination Immune Response Containment 75

BioTech 365

NOVEMBER 18, 2020

va-Q-tec Signs Extensive Heads of Terms Agreement on Provision of Thermal Containers for Global CoVid-19 Vaccine Distribution With Top International Pharmaceuticals Producer va-Q-tec Signs Extensive Heads of Terms Agreement on Provision of Thermal Containers for Global CoVid-19 Vaccine Distribution With … Continue reading →

Containment 40

Containment Vaccine Vaccination 40

Pharmaceutical Technology

MARCH 31, 2023

The European Medicines Agency (EMA) has recommended HIPRA’s Covid-19 vaccine , Bimervax, as a Covid-19 booster. Available to people ages 16 years and above who have been vaccinated with a Covid-19 mRNA vaccine, EMA’s Human Medicines Committee concluded the vaccine is ready for marketing authorization in the EU, on 30 March.

Vaccination 277

Vaccination Vaccine Immune Response Antibody 277

Fierce Pharma

AUGUST 19, 2024

With its rapid development of the Jynneos vaccine, Bavarian | After the WHO declared mpox a global health emergency for the second time in 25 months, Bavarian Nordic said it could ramp up manufacturing to supply 12 million doses of its Jynneos vaccine through 2025 to contain the virus in Africa.

Containment 88

Containment Vaccine Vaccination Manufacturing 88

Scienmag

SEPTEMBER 21, 2020

Credit: Tumisu from Pixabay New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19.

Containment 88

Containment Immune Response Vaccination Vaccine 88

Medical Xpress

FEBRUARY 7, 2023

Throughout the COVID-19 pandemic, regular testing and vaccinations of nursing home staff have been critical strategies for containing virus outbreaks in nursing homes.

Nurses 65

Nurses Vaccine Vaccination Containment 65

BioSpace

OCTOBER 21, 2020

As we resign ourselves to the fact that the epic SARS-CoV-2 virus that dominated 2020 is going to stubbornly follow us into 2021, we need to learn how to co-exist in temporary tolerance, at least until we have an effective vaccine.

Containment 73

Containment Vaccination Vaccine 73

XTalks

OCTOBER 26, 2023

The best way to prevent the flu is by getting vaccinated every year. The CDC and the World Health Organization (WHO) recommend annual flu vaccination for most people, especially those at high risk of serious complications, like pregnant women, elderly individuals, children and people with certain chronic health conditions.

Vaccine 97

Vaccine Vaccination RNA Manufacturing 97

The Pharma Data

JANUARY 3, 2021

Ltd (“ CIMC Sanctum “) recently started R&D of liquid nitrogen biological containers for long-term cryogenic storage of vaccines, stem cells, plasma, semen, embryos and various tissues and organs for the needs of the biomedical industry. SHENZHEN, China , Jan. ” About CIMC Enric Holdings Limited.

Containment 40

Containment Vaccine Vaccination Marketing 40

pharmaphorum

OCTOBER 5, 2022

million grant by the US government to develop an intranasal vaccine for gonorrhoea, a sexually-transmitted infection that is on the rise around the world. million in National Institutes of Health (NIH) funding to further develop a prophylactic vaccine based on its proprietary outer membrane vesicles (OMV) platform technology.

Vaccine 98

Vaccine Vaccination Immune Response Bacterium 98

pharmaphorum

AUGUST 23, 2021

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.

DNA 98

DNA Vaccine Vaccination Genetic Engineering 98

pharmaphorum

MARCH 2, 2021

Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.

Vaccine 119

Vaccine Vaccination Compliance Containment 119

pharmaphorum

OCTOBER 2, 2020

European regulators have started a first ‘rolling review’ of a COVID-19 vaccine, which is being developed by AstraZeneca in collaboration with the University of Oxford. But this does not mean that the CHMP is ready to make a conclusion on the safety and efficacy of the vaccine.

Regulation 105

Regulation Vaccine Vaccination Protein 105

Scienmag

MARCH 10, 2022

VANCOUVER, Wash. – A small but significant portion of couples contain one partner who is vaccinated against COVID-19 and another partner who is not, a Washington State University survey has found.

Vaccine 60

Vaccine Vaccination Containment 60

Pharmaceutical Technology

SEPTEMBER 8, 2022

The information contained within the download document is designed for pharmaceutical executives, developers, research scientists and associates, regulatory solutions consultants, and any other individual involved in API biologics production in the pharmaceutical industry.

Gene 100

Gene Marketing Vaccine Vaccination 100

Pfizer

APRIL 26, 2023

But the underlying question is always the same: How will Pfizer and BioNTech ensure a seamless distribution of our vaccine? With the pandemic still raging, our vaccine will be in high demand and, upon authorization or approval, rapidly utilized to help beat back the virus. In the U.S.,

Vaccine 52

Vaccine Vaccination Manufacturing Containment 52